AIM IMMUNOTECH INC. Long-Term Debt
AIM IMMUNOTECH INC. (AIM) had Long-Term Debt of $210.00 thousand as of 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:LongTermDebtNoncurrent · last filed 2026-08-07
- 2026-03-31: Long-term Debt, Excluding Current Maturities $210.00K.
- 2025-12-31: Long-term Debt, Excluding Current Maturities $927.00K.
- 2024-09-30: Long-term Debt, Excluding Current Maturities $139.00K.
- 2024-06-30: Long-term Debt, Excluding Current Maturities $283.00K.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2026-03-31 | $210.00K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $927.00K 10-Q · filed 2026-08-07 |
| 2024-09-30 | $139.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $283.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $950.00K 10-Q · filed 2024-05-15 |
| 2021-03-31 | $1.82M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $1.88M 10-K · filed 2022-03-31 |
| 2020-09-30 | $1.93M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $1.99M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $2.05M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $2.10M 10-K · filed 2021-03-31 |
| 2019-09-30 | $2.16M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $2.21M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $2.27M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $2.32M 10-K · filed 2020-03-30 |
| 2018-09-30 | $2.37M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $2.42M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $2.44M 10-Q · filed 2018-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |